Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (461-470 of 628) with videos related to

Pageof 63
Sort By:
Cancer Medicine|April 1, 2025
Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus ImatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
International Journal of Cancer|August 30, 2000
Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomasK Yoshikawa, T Ogawa, R Baer, et al.
Frontiers in Oncology|April 4, 2022
Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Nano Letters|September 19, 2012
Conflicting roles of nickel in controlling cathode performance in lithium ion batteriesMeng Gu, Ilias Belharouak, Arda Genc, et al.
Transplantation|December 16, 2004
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletionTheresa Hahn, Arif Raza Alam, David Lawrence, et al.
Leukemia & Lymphoma|January 23, 2019
Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosisJohn Mascarenhas, Maria R Baer, Craig Kessler, et al.
Nano Letters|March 6, 2012
In situ TEM investigation of congruent phase transition and structural evolution of nanostructured silicon/carbon anode for lithium ion batteriesChong-Min Wang, Xiaolin Li, Zhiguo Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2025
Novel O-methylpyrimidine prodrugs of phenolic compounds bioactivated by aldehyde oxidase: Enhancing metabolic stability against first-pass conjugative metabolism in the intestineJohn P Kowalski, Brian R Baer, Samuel D Randall, et al.
Cancer Research|November 3, 2001
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancersX L Xu, L C Wu, F Du, et al.
Leukemia & Lymphoma|July 12, 2018
Cryptic ETV6-PDGFRB fusion in a highly complex rearrangement of chromosomes 1, 5, and 12 due to a chromothripsis-like event in a myelodysplastic syndrome/myeloproliferative neoplasmZeba N Singh, Stephanie Richards, Firas El Chaer, et al.
Pageof 63

Showing results (461-470 of 628) with videos related to

Sort By:
Pageof 63
Cancer Medicine|April 1, 2025
Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus ImatinibAjibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
International Journal of Cancer|August 30, 2000
Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomasK Yoshikawa, T Ogawa, R Baer, et al.
Frontiers in Oncology|April 4, 2022
Impact of IDH1 c.315C>T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort StudyElizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Nano Letters|September 19, 2012
Conflicting roles of nickel in controlling cathode performance in lithium ion batteriesMeng Gu, Ilias Belharouak, Arda Genc, et al.
Transplantation|December 16, 2004
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletionTheresa Hahn, Arif Raza Alam, David Lawrence, et al.
Leukemia & Lymphoma|January 23, 2019
Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosisJohn Mascarenhas, Maria R Baer, Craig Kessler, et al.
Nano Letters|March 6, 2012
In situ TEM investigation of congruent phase transition and structural evolution of nanostructured silicon/carbon anode for lithium ion batteriesChong-Min Wang, Xiaolin Li, Zhiguo Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2025
Novel O-methylpyrimidine prodrugs of phenolic compounds bioactivated by aldehyde oxidase: Enhancing metabolic stability against first-pass conjugative metabolism in the intestineJohn P Kowalski, Brian R Baer, Samuel D Randall, et al.
Cancer Research|November 3, 2001
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancersX L Xu, L C Wu, F Du, et al.
Leukemia & Lymphoma|July 12, 2018
Cryptic ETV6-PDGFRB fusion in a highly complex rearrangement of chromosomes 1, 5, and 12 due to a chromothripsis-like event in a myelodysplastic syndrome/myeloproliferative neoplasmZeba N Singh, Stephanie Richards, Firas El Chaer, et al.
Pageof 63